NO20074703L - Antibakterielle piperidinderivater - Google Patents

Antibakterielle piperidinderivater

Info

Publication number
NO20074703L
NO20074703L NO20074703A NO20074703A NO20074703L NO 20074703 L NO20074703 L NO 20074703L NO 20074703 A NO20074703 A NO 20074703A NO 20074703 A NO20074703 A NO 20074703A NO 20074703 L NO20074703 L NO 20074703L
Authority
NO
Norway
Prior art keywords
antibacterial
piperidine derivatives
drugs
compounds
formula
Prior art date
Application number
NO20074703A
Other languages
English (en)
Inventor
George Mullen
Michael Barry Gravestock
Sheila Irene Hauck
Fei Zhou
Paul Robert Fleming
Kenneth Gregory Hull
Greg Basarab
Brian Dangel
Oluyinka Green
Pamela Hill
Brian Sherer
Haihong Ni
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074703(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20074703L publication Critical patent/NO20074703L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

Forbindelser med formel (I) og farmasøytisk akseptable salter av dem blir beskrevet. Fremgangsmåter for fremstilling av dem, farmasøytiske preparater som inneholder dem, anvendelse av dem som legemidler og anvendelse av dem ved behandling av bakterielle infeksjoner beskrives også.
NO20074703A 2005-02-18 2007-09-14 Antibakterielle piperidinderivater NO20074703L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65467005P 2005-02-18 2005-02-18
PCT/GB2006/000529 WO2006087543A1 (en) 2005-02-18 2006-02-16 Antibacterial piperidine derivatives

Publications (1)

Publication Number Publication Date
NO20074703L true NO20074703L (no) 2007-11-14

Family

ID=36218455

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074703A NO20074703L (no) 2005-02-18 2007-09-14 Antibakterielle piperidinderivater

Country Status (22)

Country Link
US (2) US8399489B2 (no)
EP (1) EP1853586B1 (no)
JP (4) JP4058106B2 (no)
KR (2) KR20070113233A (no)
CN (1) CN101163693B (no)
AR (1) AR053683A1 (no)
AU (1) AU2006215399B2 (no)
BR (1) BRPI0607756A2 (no)
CA (1) CA2598423C (no)
ES (1) ES2430569T3 (no)
HK (1) HK1114376A1 (no)
IL (1) IL185306A (no)
MX (1) MX2007010072A (no)
NO (1) NO20074703L (no)
NZ (1) NZ561613A (no)
RU (1) RU2424240C2 (no)
SA (1) SA06270020B1 (no)
TW (1) TWI402263B (no)
UA (1) UA94901C2 (no)
UY (1) UY29384A1 (no)
WO (1) WO2006087543A1 (no)
ZA (1) ZA200706920B (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
AU2006215399B2 (en) * 2005-02-18 2010-12-09 Astrazeneca Ab Antibacterial piperidine derivatives
US20090253671A1 (en) * 2005-03-04 2009-10-08 Astrazeneca Ab Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2008020229A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008020227A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
CA2675288A1 (en) 2007-01-12 2008-07-17 Astellas Pharma Inc. Condensed pyridine compound
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
WO2009081789A1 (ja) * 2007-12-26 2009-07-02 Banyu Pharmaceutical Co., Ltd. スルホニル置換六員環誘導体
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
WO2010013222A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Laboratories Limited Pyrrole carboxylic acid derivatives as antibacterial agents
JP5632379B2 (ja) * 2008-10-09 2014-11-26 アメリカ合衆国 ヒトピルビン酸キナーゼ活性化剤
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
MA32975B1 (fr) 2008-12-22 2012-01-02 Chemocentryx Inc Antagonistes de c5ar
CN102448951B (zh) 2009-04-06 2017-05-10 安吉奥斯医药品有限公司 丙酮酸激酶m2调节剂、治疗组合物和相关使用方法
CA2760929C (en) 2009-05-04 2018-01-02 Agios Pharmaceuticals, Inc. Pkm2 activators for use in the treatment of cancer
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
NZ622505A (en) 2009-06-29 2015-12-24 Agios Pharmaceuticals Inc Therapeutic compounds and compositions
EP2448581B1 (en) 2009-06-29 2016-12-07 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
TW201111380A (en) 2009-08-26 2011-04-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
SI2585064T1 (sl) 2010-06-24 2017-08-31 Chemocentryx, Inc. Antagonisti C5AR
EP2663553B1 (en) 2010-09-01 2015-08-26 Ambit Biosciences Corporation Quinoline and isoquinoline derivatives for use as jak modulators
JP5837091B2 (ja) 2010-12-17 2015-12-24 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２（ｐｋｍ２）調節剤としての新規ｎ−（４−（アゼチジン−１−カルボニル）フェニル）−（ヘテロ−）アリールスルホンアミド誘導体
JP6092118B2 (ja) 2010-12-21 2017-03-08 アジオス ファーマシューティカルズ， インコーポレイテッド ニ環式ｐｋｍ２活性化剤
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
EP2511263A1 (en) 2011-04-14 2012-10-17 Phenex Pharmaceuticals AG Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
KR20140037085A (ko) 2011-04-18 2014-03-26 메르크 파텐트 게엠베하 공액 중합체
CN103764147B (zh) 2011-05-03 2018-05-22 安吉奥斯医药品有限公司 用于治疗的丙酮酸激酶活化剂
WO2013084241A1 (en) * 2011-12-09 2013-06-13 Cadila Healthcare Limited Compounds as inhibitors of renin
JP6073931B2 (ja) * 2012-02-02 2017-02-01 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ ４−（ベンゾイミダゾール−２−イル）−チアゾール化合物及び関連するアザ誘導体
MX363432B (es) * 2013-07-22 2019-03-22 Idorsia Pharmaceuticals Ltd Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona.
ES2776395T3 (es) 2014-07-24 2020-07-30 Grace W R & Co Forma cristalina de ribósido de nicotinamida
EP3200791B1 (en) 2014-09-29 2020-04-22 ChemoCentryx, Inc. Processes and intermediates in the preparation of c5ar antagonists
KR102629310B1 (ko) 2015-03-09 2024-01-24 더블유.알. 그레이스 앤드 캄파니-콘. 니코틴아미드 리보사이드의 결정 형태
WO2016201227A1 (en) 2015-06-11 2016-12-15 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
WO2017056012A1 (en) 2015-09-30 2017-04-06 Daiichi Sankyo Company, Limited Hydroxyalkyl thiadiazole derivatives
AU2017207359C1 (en) 2016-01-14 2022-09-01 Chemocentryx, Inc. Method of treating C3 glomerulopathy
SI3798217T1 (sl) * 2016-07-28 2023-05-31 Idorsia Pharmaceuticals Ltd Piperidinski modulatorji cxcr7 receptorja
JP2020511457A (ja) 2017-03-14 2020-04-16 第一三共株式会社 ヒドロキシアルキルチアジアゾール誘導体のｎ−ホスホノキシメチルプロドラッグ
AU2018239711A1 (en) 2017-03-24 2019-11-07 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
KR102502046B1 (ko) 2018-01-26 2023-02-20 이도르시아 파마슈티컬스 리미티드 Cxcr7 수용체 작동제 (3s,4s)-1-시클로프로필메틸-4-｛[5-(2,4-디플루오로-페닐)-이속사졸-3-카르보닐]-아미노｝-피페리딘-3-카르복실산 (1-피리미딘-2-일-시클로프로필)-아미드의 결정질 형태
EP3847172A1 (en) 2018-09-03 2021-07-14 Univerza v Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
WO2022129327A1 (en) 2020-12-17 2022-06-23 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity
CN115466246B (zh) * 2021-06-11 2024-02-06 中国医学科学院药物研究所 吡咯酰哌啶胺类化合物及其用途
CN115612309B (zh) * 2022-10-14 2023-07-21 浙江博澳新材料股份有限公司 一种双杂环双酯基偶氮分散染料及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US4046775A (en) 1973-04-11 1977-09-06 Sterling Drug Inc. 4,5-Dihalopyrrole-2-carboxamides
US3963480A (en) 1973-04-11 1976-06-15 Sterling Drug Inc. Herbicidal pyrrole-2-carboxamides
US4791112A (en) 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US4912109A (en) 1987-02-02 1990-03-27 Boc, Inc. N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
FR2766488B1 (fr) 1997-07-23 2000-02-18 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
US7629360B2 (en) * 1999-05-07 2009-12-08 Celgene Corporation Methods for the treatment of cachexia and graft v. host disease
JP2003104971A (ja) 1999-08-12 2003-04-09 Wakunaga Pharmaceut Co Ltd 新規アニリド誘導体又はその塩及びこれを含有する医薬
BR0107713A (pt) 2000-01-18 2002-11-19 Vertex Pharma Inibidores de girase e usos dos mesmos
WO2001052846A1 (en) 2000-01-18 2001-07-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
TWI284639B (en) 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
WO2001096307A2 (en) 2000-06-15 2001-12-20 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DOP2002000386A (es) 2001-05-30 2002-12-15 Warner Lambert Co Agentes antibacterianos
JP4529119B2 (ja) 2001-08-09 2010-08-25 小野薬品工業株式会社 カルボン酸誘導体化合物およびその化合物を有効成分として含有する薬剤
EP1453810B1 (de) 2001-12-05 2009-03-18 Sanofi-Aventis Deutschland GmbH Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
EP1486490A1 (en) 2002-02-28 2004-12-15 Takeda Chemical Industries, Ltd. Azole compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
MXPA05003022A (es) * 2002-09-20 2005-05-27 Lupin Ltd Nuevos compuestos antimicobacterianos.
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7468364B2 (en) 2003-04-08 2008-12-23 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
SE0302116D0 (sv) 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
US7094791B2 (en) * 2003-07-31 2006-08-22 Avalon Pharmaceuticals, Inc. Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
TW200526626A (en) * 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
US7345043B2 (en) 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
WO2006030975A1 (ja) 2004-09-17 2006-03-23 Takeda Pharmaceutical Company Limited ピペリジン誘導体およびその用途
PT1807077T (pt) 2004-10-22 2017-01-06 Janssen Pharmaceutica Nv Inibidores de quinase c-fms
JP5008569B2 (ja) 2004-10-22 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃ−ｆｍｓキナーゼのインヒビターとしての芳香族アミド
WO2006087548A2 (en) 2005-02-18 2006-08-24 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
EP1856103A2 (en) 2005-02-18 2007-11-21 AstraZeneca AB Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
AU2006215399B2 (en) 2005-02-18 2010-12-09 Astrazeneca Ab Antibacterial piperidine derivatives
US20090253671A1 (en) 2005-03-04 2009-10-08 Astrazeneca Ab Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
JP2008531671A (ja) 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 化合物
US8071065B2 (en) * 2005-03-31 2011-12-06 Touchstone Research Laboratory, Ltd High density carbon foam composite tooling
BRPI0620196A2 (pt) 2005-12-23 2013-01-15 Astrazeneca Ab composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente
TW200819437A (en) 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
TW200906412A (en) 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
US8071605B2 (en) * 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections

Also Published As

Publication number Publication date
CN101163693A (zh) 2008-04-16
BRPI0607756A2 (pt) 2010-05-18
JP2008024715A (ja) 2008-02-07
US20100179150A1 (en) 2010-07-15
CN101163693B (zh) 2013-03-06
MX2007010072A (es) 2008-01-28
TWI402263B (zh) 2013-07-21
AU2006215399B2 (en) 2010-12-09
RU2424240C2 (ru) 2011-07-20
WO2006087543A8 (en) 2007-10-18
JP2007326883A (ja) 2007-12-20
EP1853586B1 (en) 2013-07-24
AU2006215399A1 (en) 2006-08-24
US20130150366A1 (en) 2013-06-13
KR20130093174A (ko) 2013-08-21
KR101422432B1 (ko) 2014-07-22
AR053683A1 (es) 2007-05-16
UA94901C2 (ru) 2011-06-25
CA2598423A1 (en) 2006-08-24
JP2008500321A (ja) 2008-01-10
CA2598423C (en) 2014-05-27
IL185306A0 (en) 2008-02-09
SA06270020B1 (ar) 2010-10-23
RU2007134380A (ru) 2009-03-27
IL185306A (en) 2012-05-31
NZ561613A (en) 2010-12-24
ZA200706920B (en) 2008-06-25
EP1853586A1 (en) 2007-11-14
US8399489B2 (en) 2013-03-19
UY29384A1 (es) 2006-10-02
ES2430569T3 (es) 2013-11-21
JP2007326882A (ja) 2007-12-20
WO2006087543A1 (en) 2006-08-24
HK1114376A1 (en) 2008-10-31
JP4058106B2 (ja) 2008-03-05
KR20070113233A (ko) 2007-11-28
TW200640908A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
NO20074703L (no) Antibakterielle piperidinderivater
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
NO20062583L (no) Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
NO20062591L (no) Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
WO2006092599A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20083863L (no) Pyrazoler som 11-beta-hsd-1
NO20076197L (no) Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
NO20076254L (no) Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20081844L (no) Terapeutiske forbindelser
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20074872L (no) Pyrazoler
NO20076137L (no) Nye 2-azetidinonderivater og deres anvendelse som kolestrolabsorpsjonsinhibitorer for behandling av hyperlipidemi
NO20082496L (no) Pyrazinderivater
MX2009013501A (es) Compuestos piperidinicos y sus usos.
WO2006087544A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
NO20072939L (no) Makroloner - aminosubstituerte kinoloner
WO2006087548A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
TW200639156A (en) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application